In this mouse model of predisposition to obesity and DT2 on account of an Ob mutation of leptin rendering the latter non-functional, IL233 treatment during or after the appearance of DT2 provides protection from diabetic nephropathy (46). The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.